Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in EBS — Emergent BioSolutions Inc.

CIK 1423053 MIAMI, FL
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Derivatives in EBS

reported options exposure · as of Jun 30, 2026
CallValue
$850,570
CallShares
101,500
PutValue
$506,990
PutShares
60,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in EBS

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $850,570 101,500
2026-06-30 $506,990 60,500
2026-03-31 $450,690 54,300
2026-03-31 $613,370 73,900
2025-12-31 $1,160,604 93,900
2025-12-31 $905,988 73,300
2025-12-31 $2,867,754 232,019
2025-09-30 $2,995,721 339,651
2025-09-30 $762,048 86,400
2025-09-30 $633,276 71,800
2025-06-30 $1,795,976 281,501
2025-06-30 $401,940 63,000
2025-06-30 $380,248 59,600
2025-03-31 $1,433,291 294,916
2025-03-31 $98,658 20,300
2025-03-31 $414,072 85,200
2024-12-31 $1,441,896 150,826
2024-12-31 $775,316 81,100
2024-12-31 $1,003,800 105,000
2024-09-30 $679,690 81,400
2024-09-30 $1,431,190 171,400
2024-09-30 $171,074 20,488
2024-06-30 $959,574 140,700
2024-06-30 $2,362,134 346,354
2024-06-30 $79,112 11,600
2024-03-31 $80,960 32,000
2024-03-31 $210,167 83,070
2024-03-31 $154,077 60,900
2023-12-31 $133,200 55,500
2023-12-31 $179,745 74,894
2023-12-31 $80,880 33,700
2023-09-30 $267,920 78,800
2023-09-30 $4,081,845 1,200,543
2023-09-30 $105,400 31,000
2023-06-30 $344,715 46,900
2023-06-30 $4,567,312 621,403
2023-06-30 $302,820 41,200
2023-03-31 $4,532,075 437,459
2023-03-31 $827,764 79,900
2023-03-31 $1,028,748 99,300
2022-12-31 $2,280,581 193,106
2022-12-31 $159,435 13,500
2022-12-31 $236,200 20,000
2022-09-30 $12,100,398 576,484
2022-09-30 $243,484 11,600
2022-09-30 $501,661 23,900
2022-06-30 $1,378,176 44,400
2022-06-30 $4,926,389 158,711
2022-06-30 $589,760 19,000
2022-03-31 $5,657,000 137,774